Dividend Details

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE2280.3011.4 (+0.5 %)
PREV CLOSE ( ) 2268.90
OPEN PRICE ( ) 2279.65
BID PRICE (QTY) 2278.95 (3)
OFFER PRICE (QTY) 2281.70 (2)
VOLUME 3396
TODAY'S LOW / HIGH ( )2252.80 2306.00
52 WK LOW / HIGH ( )1790.1 2766.85
NSE2282.057.3 (+0.32 %)
PREV CLOSE( ) 2274.75
OPEN PRICE ( ) 2261.05
BID PRICE (QTY) 2282.00 (1)
OFFER PRICE (QTY) 2283.05 (15)
VOLUME 448928
TODAY'S LOW / HIGH( ) 2253.25 2308.00
52 WK LOW / HIGH ( )1791.05 2767.1

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.